ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Gilead Sciences, Inc. proudly Supports Unite for HER's Metastatic Breast Cancer Sustainer Program





Transformative Integrative Breast Cancer Care Program Supports Metastatic Breast Cancer Patients Nationwide

PHILADELPHIA, PA, June 26, 2025 /24-7PressRelease/ -- Unite for HER (UFH) and Gilead Sciences have partnered to provide a new integrative care program free to Black, Hispanic, and underserved metastatic breast cancer patients in the United States. Through the "Metastatic Breast Cancer Sustainer Program," metastatic breast cancer patients can receive integrative therapies, services, and support at no personal cost.

"This program has been truly transformative for our members, and we are proud to partner with Gilead Sciences to bring meaningful, lasting change to their lives," said Sue Weldon, Founder and CEO of Unite for HER. "The Metastatic Breast Cancer Sustainer Program has become a vital lifeline for our members—especially for our Black, Hispanic and Latina members, and those in underserved communities. By providing access to integrative therapies such as acupuncture, professional counseling, personalized nutrition support, fitness memberships, and more at no personal cost, we're empowering members to stay on their treatment path and significantly improve their quality of life while living with cancer. This is about dignity, equity, and whole-person care."

"We are committed to advancing innovative solutions that address the unique needs of the Metastatic Breast Cancer community. We are proud to partner with Unite for HER in their mission to ensure that every patient has access to the care they need and deserve." said Carmen Villar, Senior Vice President of Global Giving, Advocacy, and Responsibility. This partnership reflects our ongoing dedication to empowering communities through meaningful, measurable impact.

Since launching in October 2023, the Unite for HER Metastatic Breast Cancer Sustainer Program has supported over 2,823 metastatic breast cancer patients in the United States. Funding from Gilead Sciences launched a new initiative of the program focused on supporting Black, Hispanic, and under-served metastatic breast cancer patients. To learn more about this program and Unite for HER's free services for breast and ovarian cancer patients in the United States, visit www.uniteforher.org.

About Unite for HER
Unite for HER is a 501(c)3 national nonprofit organization that supports breast cancer and ovarian cancer patients by providing integrative therapies, services, education, resources, and support at no personal cost. Our vision is that every person with breast and ovarian cancers will feel the support of a loving community, and will have access to comprehensive education, services, and tools that enrich their health and well-being. For more information visit uniteforher.org.

About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.